By allowing compounding pharmacies to produce certain unapproved peptides, the Department of Health and Human Services could, in the short term, put patients in harm’s way. Longer term, the policy ...
The cessation of manufacturing activities follows a Sun Pharma recall and reports that regulators found fault with the ...
Who we are We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment ...
November 2, 2026) - Okogen, Inc., a clinical-stage biotechnology company developing a host-directed antiviral platform, today ...
November 2, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading ...
In a mid-stage trial, the lower dose of Tiziana’s intranasal monoclonal antibody reduced microglial activation in a specific type of multiple sclerosis. But the path forward remains unclear after the ...
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing ...
Live audio/video webcasts of these presentations will be accessible through Eikon’s investor relations website at ...
This release fulfills the Company's October 20 announcement that next-round results on the expanded human-submitted dataset ...
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...
Nuvation Bio will present four posters: one will showcase updated long-term Phase 2 results; three posters highlight trial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results